Surgery Partners, Inc. - Common Stock (SGRY)
23.27
+0.02 (0.09%)
NASDAQ · Last Trade: Oct 27th, 4:06 PM EDT
News & Press Releases
Halper Sadeh LLC is Investigating Whether SRGY, CSR, SYNA are Obtaining Fair Deals for their Shareholders
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
By Halper Sadeh LLC · Via GlobeNewswire · October 27, 2026
SGRY Investors Have Opportunity to Join Surgery Partners, Inc. Fraud Investigation with SBS Law
Schall, Brown & Schwartz LLP (“SBS”), a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Surgery Partners, Inc. (“Surgery Partners” or “the Company”) (NASDAQ: SGRY) for potential breaches of fiduciary duty on the part of its directors and management.
By Schall, Brown & Schwartz LLP · Via Business Wire · October 26, 2026
Stock Market Today, Oct. 26: Surgery Partners Skyrockets 48% on $5.7 Billion HealthSpan Acquisitionfool.com
HealthSpan Partners agreed to buy the outpatient surgery center operator for $5.7 billion in cash, valuing shares at $23.50, today, Oct. 26, 2026.
Via The Motley Fool · October 26, 2026
US Session Top Movers: CLRO and XXII Lead Stock Gainers and Loserschartmill.com
Via Chartmill · October 26, 2026
Halper Sadeh LLC is Investigating Whether SRGY, RRC, UTZ are Obtaining Fair Deals for their Shareholders
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.
By Halper Sadeh LLC · Via GlobeNewswire · October 26, 2026
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Surgery Partners, Inc. (Nasdaq – SGRY), Range Resources Corporation (NYSE – RRC), American Oncology Network, Inc. (OTCQX – AONC), Utz Brands, Inc. (NYSE – UTZ)
BALA CYNWYD, Pa., Oct. 26, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
By Brodsky & Smith LLC · Via GlobeNewswire · October 26, 2026
Why Surgery Partners (SGRY) stock is trading up today
What happened? Shares of healthcare company Surgery Partners (NASDAQ:SGRY) jumped 46.4% in the afternoon session after HealthSpan Partners, an affiliate of B...
Via StockStory · October 26, 2026
US Session Top Percentage Movers: Gainers and Losers Among Small-Cap Stockschartmill.com
Via Chartmill · October 26, 2026
Gap Stock Movers: SGRY Leads Gap-Ups and XP Leads Gap-Downs in Today's Sessionchartmill.com
Via Chartmill · October 26, 2026
SGRY Stock Alert: Halper Sadeh LLC is Investigating Whether Surgery Partners, Inc. is Obtaining a Fair Price for its Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the sale of Surgery Partners, Inc. (NASDAQ: SGRY) to HealthSpan Partners for $23.50 in cash per share.
By Halper Sadeh LLC · Via Business Wire · October 26, 2026
Premarket Movers: Gainers and Losers Ahead of Today's US Sessionchartmill.com
Via Chartmill · October 26, 2026
HealthSpan Partners to Acquire Surgery Partners, Establishing a Leading Outpatient Surgical Care Platform
HealthSpan Partners, a contractual affiliate and supporting organization of U.S.-based Bon Secours Mercy Health (“BSMH”), and Surgery Partners, Inc. (NASDAQ:SGRY), a leading short-stay surgical facility owner and operator, today announced a definitive agreement under which HealthSpan Partners will acquire Surgery Partners in an all-cash transaction valued at an enterprise value of approximately $5.7 billion.
By HealthSpan Partners · Via Business Wire · October 26, 2026
1 of Wall Street’s favorite stocks to own for decades and 2 facing challenges
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these f...
Via StockStory · October 23, 2026
3 Profitable Stocks We’re Skeptical Of
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Via StockStory · October 16, 2026
1 Russell 2000 Stock with Competitive Advantages and 2 Facing Headwinds
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,...
Via StockStory · October 9, 2026
Surgery Partners, 10x Genomics, QuidelOrtho, Zimmer Biomet, and Tandem Diabetes Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after sentiment in the healthcare sector weakened, as the Centers for Medicare and Medicaid S...
Via StockStory · September 23, 2026
Surgery Partners (SGRY): Buy, Sell, or Hold Post Q2 Earnings?
Surgery Partners’s 30.8% return over the past six months has outpaced the S&P 500 by 12.8%, and its stock price has climbed to $15.67 per share. This was par...
Via StockStory · September 23, 2026
Surgery Partners Director Teresa DeLuca Buys 11,250 Sharesfool.com
As the stock price dips lower, this executive purchase shows confidence in the future of Surgery Partners.
Via The Motley Fool · September 3, 2026
3 Cash-Producing Stocks Walking a Fine Line
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Via StockStory · August 27, 2026
Surgery Partners (SGRY) Q2 2026 Earnings Call Transcriptfool.com
Idaho Falls sale signals shift to pure-play surgical focus.
Via The Motley Fool · August 17, 2026
The Top 5 Analyst Questions From Surgery Partners’s Q2 Earnings Call
Surgery Partners’ second quarter results were received positively by the market, with management highlighting that revenue and adjusted EBITDA came in ahead ...
Via StockStory · August 17, 2026
1 of Wall Street’s Favorite Stocks to Research Further and 2 We Avoid
Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remember...
Via StockStory · August 14, 2026
Outpatient & Specialty Care Stocks Q2 Highlights: Surgery Partners (NASDAQ:SGRY)
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the outpatient & specialty care stocks, including Surgery Partners (NASDAQ:SGRY) and it...
Via StockStory · August 12, 2026
SGRY Q2 Deep Dive: Portfolio Optimization and Acuity Mix Lead Operating Shift
Healthcare company Surgery Partners (NASDAQ:SGRY) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 2.7% year on year to $848.9 million. Th...
Via StockStory · August 11, 2026
Surgery Partners Q2 Earnings Call Highlightsmarketbeat.com
Surgery Partners (NASDAQ:SGRY) reported second-quarter 2026 revenue and adjusted EBITDA above its internal expectations, while reaffirming its full-year outlook ahead of the anticipated sale of its Idaho Falls market operations to Intermountain Health.
The company reported net revenue of approximat
Via MarketBeat · August 10, 2026